Koselugo Approved in EU for Plexiform Neurofibromas AstraZeneca's Koselugo (selumetinib) has been approved in the European Union for the treatment of symptomatic, inoperable plexiform neur…
Conversion Therapy Case a 'Pivotal Moment' Against Christian Nationalism A pending Supreme Court decision on banning conversion therapy fo…
Lahti's Most Beautiful Building Residents of Lahti, Finland have chosen a 19th-century manor house as the city's most beautiful building.
College Football: Best Finishes from Week 9 Week 9 of the college football season delivered late-game heroics, improbable comebacks, and e…
Grouchy Gunn Defends the Spycops, Blames Everyone Else The Undercover Policing Inquiry (UCPI) resumed its third tranche (T3) this week, in…
Alembic Pharma Receives USFDA Approval for Heart Disease Drug Alembic Pharmaceuticals Limited has received final approval from the US Food…
Adam's Anecdote: Politics are heating up and boiling over Our diverse society is known for its intersecting ideas and culture. However, th…
Homeland Security News Recent news highlights concerns over surveillance and national security. ICE is implementing a mass …
We Need More Faith Spaces that Affirm the LGBTQ Communities Author's summary: Faith spaces should affirm LGBTQ communities. Hearing…
Joey Foos: Building Community in Bergwall Hall Joey Foos, the current hall director of Bergwall Hall at Taylor University, has found his c…
BlockDAG's Unique TGE Code Offers VIP Early Access As 2025 approaches, the competition among top presale crypto projects is intensifying. …